Leading Artificial Cornea and Corneal Implant Disease Indication Markets

The Artificial Cornea and Corneal Implant market was valued at $598.0 Million in 2025, and is projected to reach $928.2 Million by 2032 growing at a CAGR of 6.52% from 2026 to 2032. Fuchs Dystrophy segment is expected to be the highest contributor to this market, with $364.7 Million in 2025, and is anticipated to reach $579.4 Million by 2032, registering a CAGR of 6.88%. Fuchs Dystrophy and Keratoconus segments collectively expected to account for about 83.9% share of the Artificial Cornea and Corneal Implant market in 2025, with the former constituting around 61.0% share. Fuchs Dystrophy and Keratoconus segments are expected to witness significant growth rates at a CAGR of 6.88% and 6.12% respectively, during the forecast period. Presently, share of these two segments is estimated to be around 83.9% in the overall Artificial Cornea and Corneal Implant market in 2025, and is anticipated to reach 84.7% by 2032.